The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
naltrexone · Injection, Suspension
1 marketed package NDCs · 1 active manufacturer
Most dispensed: Kit · #1 kit/carton * 4 ml in 1 vial, glass * 4 ml in 1 vial, glass
What changed in the last 90 days
Every detected change for naltrexone, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- VivitrolAug 19, 2026Price downNADAC $1716.91226 → $1716.4843 per unit (-0.02%)
- NaltrexoneAug 19, 2026New productArevipharma GmbH
- NaltrexoneAug 19, 2026New productArevipharma GmbH
- VivitrolJul 22, 2026Price downNADAC $1717.18864 → $1716.91226 per unit (-0.02%)
Common questions
- Is Naltrexone in shortage right now?
- No. FDA does not currently list Naltrexone in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Naltrexone?
- 8 companies have marketed Naltrexone in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Naltrexone cost?
- The typical pharmacy pays about $1,716.48 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.